Myocardial Injury in Severe COVID-19 is Similar to Pneumonias of Other Origin: Results from a Multicentre Study
Authors:
Open Access
- 17 December 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 8 (1) , 37-46
Abstract
Aims COVID‐19, a respiratory viral disease causing severe pneumonia, also affects the heart and other organs. Whether its cardiac involvement is a specific feature consisting of myocarditis, or simply due to microvascular injury and systemic inflammation, is yet unclear and presently debated. Because myocardial injury is also common in other kinds of pneumonias, we investigated and compared such occurrence in severe pneumonias due to COVID‐19 and other causes. Methods and results We analysed data from 156 critically ill patients requiring mechanical ventilation in four European tertiary hospitals, including all n = 76 COVID‐19 patients with severe disease course requiring at least ventilatory support, matched to n = 76 from a retrospective consecutive patient cohort of severe pneumonias of other origin (matched for age, gender, and type of ventilator therapy). When compared to the non‐COVID‐19, mortality (COVID‐19 = 38.2% vs. non‐COVID‐19 = 51.3%, P = 0.142) and impairment of systolic function were not significantly different. Surprisingly, myocardial injury was even more frequent in non‐COVID‐19 (96.4% vs. 78.1% P = 0.004). Although inflammatory activity [C‐reactive protein (CRP) and interleukin‐6] was indifferent, d‐dimer and thromboembolic incidence (COVID‐19 = 23.7% vs. non‐COVID‐19 = 5.3%, P = 0.002) driven by pulmonary embolism rates (COVID‐19 = 17.1% vs. non‐COVID‐19 = 2.6%, P = 0.005) were higher. Conclusions Myocardial injury was frequent in severe COVID‐19 requiring mechanical ventilation, but still less frequent than in similarly severe pneumonias of other origin, indicating that cardiac involvement may not be a specific feature of COVID‐19. While mortality was also similar, COVID‐19 is characterized with increased thrombogenicity and high pulmonary embolism rates.Keywords
This publication has 25 references indexed in Scilit:
- Formal guidelines: management of acute respiratory distress syndromeAnnals of Intensive Care, 2019
- Myocardial Injury in Critically Ill Patients with Community-acquired Pneumonia. A Cohort StudyAnnals of the American Thoracic Society, 2019
- Cardiac Troponin Release is Associated with Biomarkers of Inflammation and Ventricular Dilatation During Critical IllnessShock, 2017
- Optimal site for ultrasound-guided venous catheterisation in paediatric patients: an observational study to investigate predictors for catheterisation success and a randomised controlled study to determine the most successful siteCritical Care, 2015
- Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxisCritical Care, 2015
- Mechanisms of Cardiac and Renal Dysfunction in Patients Dying of SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Acute pneumonia and the cardiovascular systemThe Lancet, 2013
- Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome*Critical Care Medicine, 2007
- Left Ventricular Performance in Patients With Severe Acute Respiratory SyndromeCirculation, 2003
- Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromesJACC, 2003